OTCMKTS:NWBO - Northwest Biotherapeutics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.1980 0.00 (-1.98 %)
(As of 10/19/2018 05:44 AM ET)
Previous Close$0.2020
Today's Range$0.1920 - $0.22
52-Week Range$0.1550 - $0.3980
Volume1.57 million shs
Average Volume1.53 million shs
Market Capitalization$96.43 million
P/E RatioN/A
Dividend YieldN/A
Beta1.94
Northwest Biotherapeutics, Inc., a biotechnology company, discovers and develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. It is developing DCVax-L, a product in Phase III clinical trials to treat Glioblastome multiforme, a brain cancer; and DCVax-Direct, a product in Phase I/II clinical trials to treat various types of inoperable solid tumor cancers. The company was founded in 1996 and is headquartered in Bethesda, Maryland.

Receive NWBO News and Ratings via Email

Sign-up to receive the latest news and ratings for NWBO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:NWBO
CUSIPN/A
Phone240-497-9024

Debt

Debt-to-Equity Ratio-0.13
Current Ratio0.02
Quick Ratio0.02

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$330,000.00
Price / Sales306.51
Cash FlowN/A
Price / CashN/A
Book Value($0.20) per share
Price / Book-0.99

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-73,140,000.00
Net Margins-15,497.67%
Return on EquityN/A
Return on Assets-152.06%

Miscellaneous

Employees16
Outstanding Shares510,850,000
Market Cap$96.43 million

Northwest Biotherapeutics (OTCMKTS:NWBO) Frequently Asked Questions

What is Northwest Biotherapeutics' stock symbol?

Northwest Biotherapeutics trades on the OTCMKTS under the ticker symbol "NWBO."

How were Northwest Biotherapeutics' earnings last quarter?

Northwest Biotherapeutics, Inc (OTCMKTS:NWBO) announced its earnings results on Monday, August, 10th. The biotechnology company reported ($0.54) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.32) by $0.22. The biotechnology company had revenue of $0.39 million for the quarter, compared to analyst estimates of $0.20 million. View Northwest Biotherapeutics' Earnings History.

When is Northwest Biotherapeutics' next earnings date?

Northwest Biotherapeutics is scheduled to release their next quarterly earnings announcement on Monday, November 19th 2018. View Earnings Estimates for Northwest Biotherapeutics.

What price target have analysts set for NWBO?

0 brokers have issued twelve-month price objectives for Northwest Biotherapeutics' shares. Their forecasts range from $0.23 to $0.23. On average, they expect Northwest Biotherapeutics' share price to reach $0.23 in the next twelve months. This suggests a possible upside of 16.2% from the stock's current price. View Analyst Price Targets for Northwest Biotherapeutics.

Who are some of Northwest Biotherapeutics' key competitors?

Who are Northwest Biotherapeutics' key executives?

Northwest Biotherapeutics' management team includes the folowing people:
  • Ms. Linda F. Powers J.D., Chairperson, CEO, Pres & CFO (Age 62)
  • Dr. Alton L. Boynton, Founder, Chief Scientific Officer, Sec. & Director (Age 73)
  • Dr. Marnix L. Bosch Ph.D., MBA, Chief Technical Officer (Age 59)
  • Mr. Leslie J. Goldman, Sr. VP of Bus. Devel. (Age 73)
  • Ms. Susan Goldman, Director of Patient Affairs

How do I buy shares of Northwest Biotherapeutics?

Shares of NWBO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Northwest Biotherapeutics' stock price today?

One share of NWBO stock can currently be purchased for approximately $0.1980.

How big of a company is Northwest Biotherapeutics?

Northwest Biotherapeutics has a market capitalization of $96.43 million and generates $330,000.00 in revenue each year. Northwest Biotherapeutics employs 16 workers across the globe.

What is Northwest Biotherapeutics' official website?

The official website for Northwest Biotherapeutics is http://www.nwbio.com.

How can I contact Northwest Biotherapeutics?

Northwest Biotherapeutics' mailing address is 4800 MONTGOMERY LANE SUITE 800, BETHESDA MD, 20814. The biotechnology company can be reached via phone at 240-497-9024 or via email at [email protected]


MarketBeat Community Rating for Northwest Biotherapeutics (OTCMKTS NWBO)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  79 (Vote Outperform)
Underperform Votes:  80 (Vote Underperform)
Total Votes:  159
MarketBeat's community ratings are surveys of what our community members think about Northwest Biotherapeutics and other stocks. Vote "Outperform" if you believe NWBO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NWBO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel